CL2015002599A1 - Composiciones y métodos para la orientación de n-acetilglucosamina transferasa unida al oxigeno y promover sanamiento de heridas - Google Patents
Composiciones y métodos para la orientación de n-acetilglucosamina transferasa unida al oxigeno y promover sanamiento de heridasInfo
- Publication number
- CL2015002599A1 CL2015002599A1 CL2015002599A CL2015002599A CL2015002599A1 CL 2015002599 A1 CL2015002599 A1 CL 2015002599A1 CL 2015002599 A CL2015002599 A CL 2015002599A CL 2015002599 A CL2015002599 A CL 2015002599A CL 2015002599 A1 CL2015002599 A1 CL 2015002599A1
- Authority
- CL
- Chile
- Prior art keywords
- linked
- compositions
- methods
- wound healing
- promoting wound
- Prior art date
Links
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 title 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 title 1
- 102000004357 Transferases Human genes 0.000 title 1
- 108090000992 Transferases Proteins 0.000 title 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229950006780 n-acetylglucosamine Drugs 0.000 title 1
- 229910052760 oxygen Inorganic materials 0.000 title 1
- 239000001301 oxygen Substances 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
- 230000029663 wound healing Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01186—Glycogenin glucosyltransferase (2.4.1.186)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01255—Protein O-GlcNAc transferase (2.4.1.255)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Power Engineering (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Inorganic Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361775937P | 2013-03-11 | 2013-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2015002599A1 true CL2015002599A1 (es) | 2016-08-26 |
Family
ID=51658978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2015002599A CL2015002599A1 (es) | 2013-03-11 | 2015-09-11 | Composiciones y métodos para la orientación de n-acetilglucosamina transferasa unida al oxigeno y promover sanamiento de heridas |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20170166897A1 (enExample) |
| EP (1) | EP2970978A4 (enExample) |
| JP (1) | JP2016513968A (enExample) |
| KR (1) | KR20150126048A (enExample) |
| CN (1) | CN105408480A (enExample) |
| AU (1) | AU2014248966A1 (enExample) |
| BR (1) | BR112015022701A2 (enExample) |
| CA (1) | CA2905337A1 (enExample) |
| CL (1) | CL2015002599A1 (enExample) |
| MX (1) | MX2015012124A (enExample) |
| RU (1) | RU2015138544A (enExample) |
| SG (1) | SG11201507211YA (enExample) |
| WO (1) | WO2014164805A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020117937A1 (en) * | 2018-12-06 | 2020-06-11 | Bio Capital Holdings, LLC | Glucose sensors and methods of use thereof |
| CN111234022B (zh) * | 2019-12-16 | 2024-03-22 | 江苏省药物研究所有限公司 | 抗n-乙酰氨基葡萄糖转移酶修饰的蛋白质单克隆抗体及杂交瘤细胞株和其制备方法与应用 |
| CN112707955B (zh) * | 2020-12-21 | 2022-01-18 | 山东润德生物科技有限公司 | 提高N-乙酰氨基葡萄糖产量的RamAM转录因子突变体 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL108367A0 (en) * | 1993-01-27 | 1994-04-12 | Hektoen Inst For Medical Resea | Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells |
| AU6942598A (en) * | 1997-03-31 | 1998-10-22 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | O-linked glcnac transferase (ogt): cloning, molecular expression, and methods ofuse |
| CA2333901A1 (en) * | 1998-08-03 | 2000-02-24 | East Carolina University | Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments |
| EP1621212B1 (en) * | 1999-01-27 | 2011-11-16 | Coda Therapeutics, Inc. | Formulations comprising antisense nucleotides to connexins |
| CN101356437B (zh) * | 2005-12-22 | 2012-08-01 | J-油坊株式会社 | 具有由GnT-V转移的GlcNAc的糖链的检测方法 |
| US20110257034A1 (en) * | 2008-10-10 | 2011-10-20 | Cornell University | Methods for identifying genes which predict disease outcome for patients with colon cancer |
| US20120046186A1 (en) * | 2010-08-20 | 2012-02-23 | Pelham Robert J | Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs |
| JP2012083193A (ja) * | 2010-10-12 | 2012-04-26 | Univ Of Tokyo | ヒストンタンパク質のグリコシル化を検出するための方法、並びに当該方法に用いられる抗体 |
-
2014
- 2014-03-11 BR BR112015022701A patent/BR112015022701A2/pt not_active IP Right Cessation
- 2014-03-11 EP EP14779180.0A patent/EP2970978A4/en not_active Withdrawn
- 2014-03-11 WO PCT/US2014/023525 patent/WO2014164805A1/en not_active Ceased
- 2014-03-11 MX MX2015012124A patent/MX2015012124A/es unknown
- 2014-03-11 KR KR1020157028279A patent/KR20150126048A/ko not_active Withdrawn
- 2014-03-11 RU RU2015138544A patent/RU2015138544A/ru not_active Application Discontinuation
- 2014-03-11 US US14/774,800 patent/US20170166897A1/en not_active Abandoned
- 2014-03-11 JP JP2016501273A patent/JP2016513968A/ja not_active Withdrawn
- 2014-03-11 AU AU2014248966A patent/AU2014248966A1/en not_active Abandoned
- 2014-03-11 CN CN201480026966.0A patent/CN105408480A/zh active Pending
- 2014-03-11 SG SG11201507211YA patent/SG11201507211YA/en unknown
- 2014-03-11 CA CA2905337A patent/CA2905337A1/en not_active Abandoned
-
2015
- 2015-09-11 CL CL2015002599A patent/CL2015002599A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2970978A4 (en) | 2016-11-02 |
| WO2014164805A1 (en) | 2014-10-09 |
| SG11201507211YA (en) | 2015-10-29 |
| US20170166897A1 (en) | 2017-06-15 |
| BR112015022701A2 (pt) | 2018-09-25 |
| CA2905337A1 (en) | 2014-10-09 |
| AU2014248966A1 (en) | 2015-10-29 |
| CN105408480A (zh) | 2016-03-16 |
| EP2970978A1 (en) | 2016-01-20 |
| KR20150126048A (ko) | 2015-11-10 |
| MX2015012124A (es) | 2016-04-28 |
| RU2015138544A (ru) | 2017-04-18 |
| JP2016513968A (ja) | 2016-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282202A (en) | Compositions and methods for personalized neoplasia vaccines | |
| IL267681B (en) | Selective grp94 inhibitors and uses thereof | |
| IL241112B (en) | Methods and compositions for modification of hla | |
| EP2964155A4 (en) | BONE PILLOW | |
| HRP20180817T1 (hr) | Sastavi i postupci za modulaciju farnesoid-x-receptora | |
| BR112015028115A2 (pt) | métodos e composições para o tratamento de câncer | |
| DK2994173T3 (en) | Wound healing and tissue engineering | |
| CL2015002146A1 (es) | Composiciones y procedimientos para tratar heridas superficiales | |
| PL3007687T3 (pl) | Kombinacja pentacyklicznych triterpenów i hydroksytyrozolu oraz jego pochodnych | |
| EP3052510A4 (en) | Methods and compositions for treating and/or preventing mucositis | |
| ZA201602770B (en) | Tyrosine derivatives and compositions comprising them | |
| CL2016001220A1 (es) | Gasa quirurgica | |
| ZA201508186B (en) | Methods and compositions for wound healing | |
| FR3014969B1 (fr) | Fixation temporaire | |
| CL2016001382A1 (es) | Estabilidad de gel mejorada | |
| KR101391404B9 (ko) | 골신장기 | |
| PT3613423T (pt) | Composições de hialuronano de elevada elasticidade e suas utilizações | |
| CL2015002599A1 (es) | Composiciones y métodos para la orientación de n-acetilglucosamina transferasa unida al oxigeno y promover sanamiento de heridas | |
| IL243288B (en) | Enhancement of osteogenic potential of bone grafts | |
| BR112015023621A8 (pt) | derivados de meropenem e suas utilizações | |
| EP3046544A4 (en) | Methods of preventing or treating mucositis using rlip76 | |
| BR302014001268S1 (pt) | Configuração aplicada em pinça para alimentos | |
| FR3007963B1 (fr) | Corset orthopedique evolutif | |
| TH1501001641A (th) | อนุพันธ์กรดไฮยาลูโรนิกที่ถูกดัดแปลงและการใช้สารนั้น | |
| BR302013004961S1 (pt) | Configuração aplicada em vasilha para alimentos |